How Will Moderna Meet The Demand For Its COVID-19 Vaccine?
Update RequiredTo play audio, update browser or Flash plugin.
A worker passes through the security gate at the Moderna campus in Norwood, Mass., one of the sites where the biotechnology company is manufacturing its COVID-19 vaccine.
Joseph Prezioso / AFP via Getty Images
Moderna s COVID-19 vaccine is expected to become the second to get the Food and Drug Administration s green light. A decision could come within days.
But compared with pharmaceutical giant Pfizer, which was granted emergency use authorization last week, upstart Moderna doesn t have a track record when it comes to mass production.
Joseph Prezioso/AFP via Getty Images
hide caption
toggle caption Joseph Prezioso/AFP via Getty Images
A worker passes through the security gate at the Moderna campus in Norwood, Mass., one of the sites where the biotechnology company is manufacturing its COVID-19 vaccine. Joseph Prezioso/AFP via Getty Images
Moderna s COVID-19 vaccine is expected to become the second to get the Food and Drug Administration s green light. A decision could come within days.
But compared with pharmaceutical giant Pfizer, which was granted emergency use authorization last week, upstart Moderna doesn t have a track record when it comes to mass production.